AstraZeneca officer buys 21.233 shares via plans

AstraZeneca SVP Sharma Mani reported small share acquisitions via company share plans, including dividend reinvestment units that vest after a three-year holding period.

Rhea-AI Filing Summary

ASTRAZENECA PLC (AZN) reported insider share acquisitions by officer Sharma Mani, Senior Vice President, Group Controller and Head of Global Finance Services. On August 8, 2026, Mani acquired 20.233 Ordinary Shares through automatic dividend reinvestment linked to a Restricted Share Plan. On September 8, 2026, Mani acquired 1 Ordinary Share under a Share Incentive Plan. No Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Net Buyer: 20.233 shares

Net Buy 2 txns

Insider Sharma Mani

Role See Remarks

Bought 20.233 shs ($3K)

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares F2	1	$162.60	$162.60
Purchase	Ordinary Shares F1	20.233	$160.57	$3K

Holdings After Transaction: Ordinary Shares — 19,288.6989 shares (Direct)

Footnotes (2)

1. F1. Represents the automatic reinvestment of dividends accrued during the holding period of the Issuer's Restricted Share Plan, at a price of GBP118.96, which has been converted from British pounds sterling to United States dollars at a conversion rate of GBP1.0000 to $1.3498 on August 7, 2026 as published by the Board of Governors of the Federal Reserve System. The dividend equivalent units will vest and be released to the Officer at the end of the three year holding period.
2. F2. Represents the acquisition of shares pursuant to the Issuer's Share Incentive Plan at a price of GBP120.26, which has been converted from British pounds sterling to United States dollars at a conversion rate of GBP1.0000 to $1.3521 on September 4, 2026 as published by the Board of Governors of the Federal Reserve System.

Key Figures

Shares acquired via dividend reinvestment: 20.233 shares Price per share (dividend reinvestment acquisition): $160.57 per share Shares acquired under Share Incentive Plan: 1 share +4 more

7 metrics

Shares acquired via dividend reinvestment 20.233 shares Automatic reinvestment under Restricted Share Plan on August 8, 2026

Price per share (dividend reinvestment acquisition) $160.57 per share Converted from GBP118.96 at GBP1.0000 = $1.3498

Shares acquired under Share Incentive Plan 1 share Acquisition on September 8, 2026

Price per share (Share Incentive Plan acquisition) $162.60 per share Converted from GBP120.26 at GBP1.0000 = $1.3521

Restricted Share Plan holding period 3 years Dividend equivalent units vest and release at end of three-year period

FX rate for August 8, 2026 transaction GBP1.0000 = $1.3498 Used to convert GBP118.96 price for dividend reinvestment

FX rate for September 8, 2026 transaction GBP1.0000 = $1.3521 Used to convert GBP120.26 price for Share Incentive Plan

Key Terms

Restricted Share Plan, Share Incentive Plan, dividend equivalent units

3 terms

Restricted Share Plan financial

"automatic reinvestment of dividends accrued during the holding period of the Issuer's Restricted Share Plan"

Share Incentive Plan financial

"acquisition of shares pursuant to the Issuer's Share Incentive Plan at a price of GBP120.26"

A share incentive plan is a company program that gives employees or directors the chance to receive or buy company shares, often after staying with the firm or meeting performance goals. It matters to investors because it’s like giving workers a slice of the company pie to boost performance and loyalty, but issuing those slices can reduce each existing owner’s portion and change metrics such as earnings per share and share count.

dividend equivalent units financial

"The dividend equivalent units will vest and be released to the Officer at the end"

Dividend equivalent units are bookkeeping credits that mirror cash dividends paid on actual shares, granted to holders of stock-based awards such as restricted stock units or deferred compensation. They matter to investors because they increase a company’s reported employee compensation cost and can lead to issuance of more shares or cash payouts over time, similar to extra pay linked to ownership that affects shareholder dilution and corporate cash flow.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did AZN officer Sharma Mani report?

Sharma Mani reported two acquisitions of AstraZeneca Ordinary Shares: 20.233 shares on August 8, 2026 via dividend reinvestment under a Restricted Share Plan, and 1 share on September 8, 2026 acquired through the Issuer's Share Incentive Plan.

How many AstraZeneca (AZN) shares did Sharma Mani buy and at what prices?

Mani acquired 20.233 shares at $160.57 per share on August 8, 2026 through dividend reinvestment and 1 share at $162.60 on September 8, 2026 under a Share Incentive Plan, with U.S. dollar prices derived from stated GBP amounts and FX rates.

Were Sharma Mani’s AZN transactions under a Rule 10b5-1 trading plan?

No. The filing indicates no Rule 10b5-1 plan applies to these transactions, meaning they are not reported as having been executed under a pre-arranged trading plan.

What is the nature of the 20.233 AZN shares reported for August 8, 2026?

The 20.233 shares represent automatic reinvestment of dividends accrued during the holding period of AstraZeneca’s Restricted Share Plan, creating dividend equivalent units that will vest and be released at the end of a three-year holding period.

How were foreign exchange rates used in Sharma Mani’s AZN Form 4?

The filing states GBP prices converted to U.S. dollars: GBP1.0000 = $1.3498 on August 7, 2026 for the Restricted Share Plan reinvestment, and GBP1.0000 = $1.3521 on September 4, 2026 for the Share Incentive Plan acquisition.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/11/2026 - 04:06 PM Accepted by SEC EDGAR 09/11/2026 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sharma Mani

(Last) (First) (Middle)

C/O ASTRAZENECA PLC 1 FRANCIS

CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS

(Street)

CAMBRIDGE CB2 0AA

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
ASTRAZENECA PLC [ AZN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/08/2026		P		20.233	A	$160.57(1)	19,287.6989	D
Ordinary Shares	09/08/2026		A		1	A	$162.6(2)	19,288.6989	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the automatic reinvestment of dividends accrued during the holding period of the Issuer's Restricted Share Plan, at a price of GBP118.96, which has been converted from British pounds sterling to United States dollars at a conversion rate of GBP1.0000 to $1.3498 on August 7, 2026 as published by the Board of Governors of the Federal Reserve System. The dividend equivalent units will vest and be released to the Officer at the end of the three year holding period.

2. Represents the acquisition of shares pursuant to the Issuer's Share Incentive Plan at a price of GBP120.26, which has been converted from British pounds sterling to United States dollars at a conversion rate of GBP1.0000 to $1.3521 on September 4, 2026 as published by the Board of Governors of the Federal Reserve System.

Remarks:

SVP, Group Controller and Head of Global Finance Services

	/s/ Mani Sharma	09/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)